Genetic elements promote retention of extrachromosomal DNA in cancer cells
- PMID: 41261124
- PMCID: PMC12727538
- DOI: 10.1038/s41586-025-09764-8
Genetic elements promote retention of extrachromosomal DNA in cancer cells
Abstract
Extrachromosomal DNA (ecDNA) is a prevalent and devastating form of oncogene amplification in cancer1,2. Circular megabase-sized ecDNAs lack centromeres, stochastically segregate during cell division3-6 and persist over many generations. It has been more than 40 years since ecDNAs were first observed to hitchhike on mitotic chromosomes into daughter cell nuclei, but the mechanism underlying this process remains unclear3,7. Here we identify a family of human genomic elements, termed retention elements, that tether episomes to mitotic chromosomes to increase ecDNA transmission to daughter cells. Using Retain-seq, a genome-scale assay that we developed, we reveal thousands of human retention elements that confer generational persistence to heterologous episomes. Retention elements comprise a select set of CpG-rich gene promoters and act additively. Live-cell imaging and chromosome conformation capture show that retention elements physically interact with mitotic chromosomes at regions that are mitotically bookmarked by transcription factors and chromatin proteins. This activity intermolecularly recapitulates promoter-enhancer interactions. Multiple retention elements are co-amplified with oncogenes on individual ecDNAs in human cancers and shape their sizes and structures. CpG-rich retention elements are focally hypomethylated. Targeted cytosine methylation abrogates retention activity and leads to ecDNA loss, which suggests that methylation-sensitive interactions modulate episomal DNA retention. These results highlight the DNA elements and regulatory logic of mitotic ecDNA retention. Amplifications of retention elements promote the maintenance of oncogenic ecDNA across generations of cancer cells, and reveal the principles of episome immortality intrinsic to the human genome.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: H.Y.C. is an employee and stockholder of Amgen as of 16 December 2024. H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics, and was an advisor of Arsenal Biosciences, Chroma Medicine, Exai Bio and Vida Ventures until 15 December 2024. P.S.M. is a co-founder and advisor of Boundless Bio. A.G.H. is a founder and shareholder of Econic Biosciences. M.G.J. is a consultant for and holds equity in Vevo Therapeutics. The remaining authors declare no competing interests.
Figures
Update of
-
Genetic elements promote retention of extrachromosomal DNA in cancer cells.bioRxiv [Preprint]. 2025 Oct 12:2025.10.10.681495. doi: 10.1101/2025.10.10.681495. bioRxiv. 2025. Update in: Nature. 2026 Jan;649(8095):152-160. doi: 10.1038/s41586-025-09764-8. PMID: 41278658 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
